By Matt Agorist Despite the overwhelming evidence showing that kidnapping and caging people for possessing illegal substances does nothing to prevent use and only leads to more crime and suffering, government is still hell-bent on enforcing the war on drugs. Like a crack addict who…
By Elias Marat The hallucinogenic drug DMT (dimethyltriptamine) could provide crucial aid to stroke victims by minimizing the damage inflicted on victims’ brains as they are rushed to the hospital, according to researchers. Canadian company Algernon Pharmaceuticals has laid out plans to microdose participants in…
By Dylan Charles The opioid crisis rages on behind the scenes of Covid and every other thing occupying public attention, and in many big cities last year the crisis has deepened. For example, in heavily locked down San Francisco, 360% more people died from overdoses…
By Mike Sygula Filmmaker Ben Stewart who created iconic documentaries such as Kymatica and Esoteric Agenda shares his new film that looks into the science behind the visionary compound known as DMT. The film features some of the biggest names in the psychedelic scene, people…
By Matt Agorist Despite the overwhelming evidence showing that kidnapping and caging people for possessing illegal substances does nothing to prevent use and only leads to more crime and suffering, government is still hell bent on enforcing the war on drugs. Like a crack addict…
By Elias Marat Regulators in the U.K. are set to begin the first-ever clinical trial of dimethyltriptamine (DMT) in hopes to gain a better understanding of how the psychedelic drug can be used to treat various mental health disorders, such as depression. The drug was…
In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving…
By Elias Marat The city of Ann Arbor, Michigan, has effectively decriminalized psilocybin or “magic” mushrooms along with other natural psychedelics in the latest sign that public opinion across the U.S. is continuing to turn against prohibitionist policies. On Monday, the Ann Arbor City Council…
By John Vibes A DMT church in Winnipeg, Canada was recently granted a government exemption to legally import and use Daime tea, which is a DMT-based brew very similar to ayahuasca, but a little bit less potent. The church is called “The Centre for Universal…
By John Vibes Research published in Frontiers in Psychiatry this month has suggested that psychedelic experiences can reduce levels of depression by helping patients come to terms with their emotions and their memories. The authors of a new research article pointed to a series of…
By Matt Agorist The fact that any people have to get permission from their government to ingest a fungus that grows wildly in all corners of the globe is infuriating. Even more infuriating, however, is the fact that terminally ill cancer patients have to get…
By John Vibes A study published last month in the journal Neuropsychopharmacology has shown that psychedelic experiences can dissolve the ego, which is something that psychedelic advocates have been saying for decades. In the study, researchers looked at how psilocybin affects glutamate activity in the…
Perhaps no region of the brain is more fittingly named than the claustrum, taken from the Latin word for “hidden or shut away.” The claustrum is an extremely thin sheet of neurons deep within the cortex, yet it reaches out to every other region of…
Scientists prove that psilocybin, a potential drug for treating depression and other psychological conditions can be produced in yeast. Psilocybin mushrooms have been found to have minimal harmful effects and could potentially benefit those with depression. But they remain illegal even though they offer a…
By Aaron Kesel Several companies that are developing medical treatments from psychedelic drugs like LSD, ketamine, and psilocybin—the active ingredient in magic mushrooms—are getting ready to list on Canadian stock exchanges. One of those companies, Mind Medicine Inc., has been involved in clinical trials of…
By John Vibes More research continues to be published showing the potential impact that psychedelic compounds can have on mental health treatment. A team at New York University‘s Grossman School of Medicine recently conducted followup research to the 2016 study which showed that cancer patients…
By John Vibes In light of the growing scientific evidence showing the possibility for therapeutic uses of psychedelic compounds, these substances are slowly becoming more acceptable in mainstream circles. At the most recent World Economic Forum in Davos, where wealthy and influential people meet to…
People who had recently used psychedelics such as psilocybin report a sustained improvement in mood and feeling closer to others after the high has worn off, shows a new Yale study published the week of Jan. 20 in the journal Proceedings of the National Academy…
By Elias Marat In an unsettling sign of potential things to come, last week a company successfully trademarked the word “psilocybin”—yes, the same word for the psychoactive compound of the popular psychedelic “magic mushrooms.” The company, Psilocybin—or rather, Psilocybin™—is actually a chocolatier that doesn’t even…
By John Vibes A set of clinical trials for MDMA, sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has now reached “Phase 3,” which brings the substance just a few steps away from getting approved by the US Food and Drug Administration (FDA)….
